Publication details
Nivolumab v léčbě NSCLC
Title in English | Nivolumab in the therapy of NSCLC |
---|---|
Authors | |
Year of publication | 2018 |
Type | Article in Periodical |
Magazine / Source | Farmakoterapie |
MU Faculty or unit | |
Citation | |
Keywords | nivolumab; squamous lung cancer; nonsquamous lung cancer; NSCLC |
Description | Nivolumab is fully human IgG4 antibody that selectively blocks the interaction between PD-1 and PD-L1/PD-L2 and restarts the immune respone against tumor cells. |